I also don't think this will create a major re-rate. While critical for expanding Nuheara's market share into a very lucrative area - it won't make didly squat difference to the bottom line this year (I believe). Re-rate to happen later when IQbuds are approved as OTC hearing assistance devices and when they start going on shelves as such
I also don't think this will create a major re-rate. While...
Add NUH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NUH (ASX) Chart |
Day chart unavailable